EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A review on mechanistic actions of epigallocatechin-3-gallate in targeting the ominous octet of type 2 diabetes mellitus

Chee Ning Wong, Yang Mooi Lim, Kai Bin Liew, Yik-Ling Chew, Ang-Lim Chua, Siew-Keah Lee

Journal of Integrative Medicine · 2025-07 · 23 (4) · 344-356

DOI: 10.1016/j.joim.2025.05.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Integrative Medicine, 2025-07. Verfasst von Chee Ning Wong und 5 weiteren Autor:innen. Beteiligte Einrichtung: M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, 43000 Kajang, Selangor, Malaysia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Catechin, Hypoglycemic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 113 Literaturangaben. Gefördert von: Malaysia Ministry of Higher Education, Universiti Tunku Abdul Rahman.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigallocatechin-3-gallate (EGCG), a prominent plant-based catechin predominantly derived from Camellia sinensis and widely available on the market as a health supplement, has garnered significant attention for its potential therapeutic benefits, particularly in the context of type 2 diabetes mellitus (T2DM). This review explores the multifaceted role of EGCG in addressing the "ominous octet"-the 8 core pathophysiological defects associated with T2DM. The literature search was carried out using key terms "EGCG" OR "epigallocatechin-3-gallate" OR "epigallocatechin gallate" AND "diabetes" OR "insulin resistance" OR "hyperglycemia" in the PubMed and Scopus databases. The search was constrained to articles published between January 2018 and April 2024, focusing on the document type. Full-text articles published in English and relevant to EGCG that featured a single active ingredient, included clearly explained diabetes relief mechanism, and included ominous octet aspects were included in the final review. The outcomes of the included studies were reviewed and categorized based on 8 core pathophysiological defects, collectively referred to as the ominous octet in T2DM. This review concludes that EGCG is a potent hypoglycemic agent that has beneficial effects against the ominous octet in addition to its pharmacological activities in modulating gut microbiota dysbiosis, carbohydrate digestion and metabolism, glucose transporter-mediated intestinal glucose-uptake, endothelial dysfunction, and renal damage that are significantly associated with pathogenesis of T2DM. This extensive scientific evidence suggests that EGCG may offer a novel approach to traditional antidiabetic therapies, potentially improving glycemic control and mitigating complications associated with T2DM. The inhibitory effects of EGCG on sodium-glucose transport proteins and their role in reducing renal glucose reabsorption remain unexplored, highlighting a significant research gap. Future research should also aim to broaden the scope by investigating the "egregious eleven," which comprise a more comprehensive range of diabetic pathophysiological features. This review underscores the therapeutic promise of EGCG for managing T2DM and encourages ongoing research to fully elucidate its clinical applications. Please cite this article as: Wong CN, Lim YM, Liew KB, Chew YL, Chua AL, Lee SK. A review on mechanistic actions of epigallocatechin-3-gallate in targeting the ominous octet of type 2 diabetes mellitus. J Integr Med. 2025; 23(4): 344-356.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2CatechinHypoglycemic AgentsHumansAnimalsInsulin Resistance

Stichwörter der Autor:innen

CatechinDiabetes mellitusEpigallocatechin-3-gallateHyperglycemiaInsulin resistanceOminous octet

Substanzen

Catechinepigallocatechin gallateHypoglycemic Agents

Autor:innen und Institutionen

  • M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, 43000 Kajang, Selangor, Malaysia.
  • Faculty of Pharmacy, University of Cyberjaya, 63000 Cyberjaya, Selangor, Malaysia.
  • Faculty of Pharmaceutical Sciences, UCSI University, 56000 Cheras, Kuala Lumpur, Malaysia.
  • Faculty of Medicine, Universiti Teknologi MARA, 47000 Sungai Buloh, Selangor, Malaysia.
  • M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, 43000 Kajang, Selangor, Malaysia. Electronic address: leesiewkeah@utar.edu.my.

Förderung

  • Malaysia Ministry of Higher Education
  • Universiti Tunku Abdul Rahman

Zitieren

APA

Wong, C. N., Lim, Y. M., Liew, K. B., Chew, Y. L., Chua, A. L., & Lee, S. K. (2025). A review on mechanistic actions of epigallocatechin-3-gallate in targeting the ominous octet of type 2 diabetes mellitus. Journal of Integrative Medicine, 23(4), 344-356. https://doi.org/10.1016/j.joim.2025.05.005

Vancouver

Wong CN, Lim YM, Liew KB, Chew YL, Chua AL, Lee SK. A review on mechanistic actions of epigallocatechin-3-gallate in targeting the ominous octet of type 2 diabetes mellitus. Journal of Integrative Medicine. 2025;23(4):344-356. doi:10.1016/j.joim.2025.05.005

BibTeX
@article{Wong2025,
  author = {Wong, Chee Ning and Lim, Yang Mooi and Liew, Kai Bin and Chew, Yik-Ling and Chua, Ang-Lim and Lee, Siew-Keah},
  title = {A review on mechanistic actions of epigallocatechin-3-gallate in targeting the ominous octet of type 2 diabetes mellitus},
  journal = {Journal of Integrative Medicine},
  year = {2025},
  volume = {23},
  number = {4},
  pages = {344--356},
  doi = {10.1016/j.joim.2025.05.005}
}
Kostenlos starten →